Logo
Login
Sign Up

Archive

What Benchling's 2026 Report Actually Tells Us

Jan 13, 2026

The data tells a more interesting story than the summary.

Read More

Why Did Lilly Just Gave Away $1 Billion in AI Models?

Jan 9, 2026

Discovery tools are commoditizing. Value is moving downstream.

Read More

The Holiday Recap: Dec 23 – Jan 5

Jan 6, 2026

Two major acquisitions. One landmark IPO. And a brutal reminder that biology doesn't care about your biomarkers.

Read More

Two Updates for 2026

Jan 2, 2026

Thinking Folds is expanding. Here's what's changing.

Read More

The $70M Bet That AI Can Solve Drug Discovery's Biggest Problem

Dec 19, 2025

71% of drugs fail because scientists pick the wrong target. Edison thinks AI can fix that. But Can It?

Read More

The $4 Million Problem

Dec 12, 2025

How a $25M startup is solving gene therapy's $4 million payment problem

Read More

Why J&J is paying a Dutch startup to design proteins with AI

Dec 5, 2025

Cradle Bio's AI designs better proteins in fewer experiments—turning biology into an engineering problem.

Read More

Thinking Folds

Where biotech innovation meets commercial reality, unfolding the stories of scientific breakthroughs becoming venture-backed startups.

Advertise

© 2026 Thinking Folds.

Report abuse

Privacy policy

Terms of use

Powered by beehiiv